MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targetingSilvia Pomella, Rossella Rota|Nature Communications|2023Cited by 21
A MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targetingSilvia Pomella, Rossella Rota|Research Square|2022Cited by 1